Oct 19: What's Next in Real World Evidence?

Real World Evidence (RWE) has the potential to hypercharge medical innovation. In fact, the collection and analysis of such information — derived from wearables, electronic health records, and other sources — has become a $16 billion business. According to Pitchbook (https://bit.ly/38vKAgJ) 57 RWE startups collectively raised $1.8 billion since 2019 and the market is projected to grow 15% per year through 2027.

On Tuesday, October 19th, 10am ET, meet five prominent global epidemiologists and data scientists from AstraZeneca, Novartis, J&J, Boehringer Ingelheim and ISPOR (International Society for Pharmaeconomics and Outcomes Research) driving the future of Real World Data, followed by two world class RWE startups (Duality and Medisafe).

Date: Tues, Oct 19th
Time: 10am ET / 5pm IL
Join URL: https://bit.ly/3jDXzTS

Welcome Remarks:
Richard Willke, Chief Science Officer, ISPOR (International Society for Pharmaeconomics and Outcomes Research)
Bio: https://www.linkedin.com/in/richard-willke-02a25a3

Speakers:
Amy Rudolph, Global Head, Evidence and Launch Excellence, Novartis
Bio: https://www.linkedin.com/in/amy-rudolph-4a749639

Paul Coplan, VP and Head, Medical Device Epidemiology & Real World Data Sciences, Johnson & Johnson
Bio: https://www.linkedin.com/in/paul-coplan-2430768

Presentation by Paul Coplan:
https://www.slideshare.net/levshapiro/paul-coplan-vp-johnson-johnsonmhealth-israel

Michael Seewald, VP Global Evidence, Medical BioPharmaceuticals, AstraZeneca
Bio: https://www.linkedin.com/in/michaelseewald

Presentation by Michael Seewald: https://www.slideshare.net/levshapiro/realworld-data-whats-next-by-michael-seewald-astrazeneca-for-mhealth-israel

Paul Petraro, Executive Director, Global Head Real World Evidence Analytic (RWE) Center of Excellence, Boehringer-Ingelheim
Bio: https://www.linkedin.com/in/paul-petraro-b5318524

Moderator: Gil Bashe, Chair, Global Health, Finn Partners AND Top 10 Digital Health Influencer
Bio: https://www.linkedin.com/in/gilbashe

Part I
RWE Startup Showcase:

• Alon Kaufman, CEO, Duality Technologies
  https://www.linkedin.com/in/alon-kaufman-24067b154
  Presentation: https://www.slideshare.net/levshapiro/duality-technologiesdriving-secure-collaboration-in-healthcaremhealth-israel

• Omri Shor, CEO, Medisafe
  https://www.linkedin.com/in/omrishor
  Presentation: https://www.slideshare.net/levshapiro/medisafewhats-next-in-rwemhealth-israel

Part II
Corporate Keynotes:
I. Paul Coplan, VP and Head, Medical Device Epidemiology & Real World Data Sciences, Johnson & Johnson
Bio: https://www.linkedin.com/in/paul-coplan-2430768

II: Michael Seewald, VP Global Evidence, Medical BioPharmaceuticals, AstraZeneca
Bio: https://www.linkedin.com/in/michaelseewald

III. Paul Petraro, Executive Director, Global Head Real World Evidence Analytic (RWE) Center of Excellence, Boehringer-Ingelheim
Bio: https://www.linkedin.com/in/paul-petraro-b5318524

IV: Amy Rudolph, Global Head, Evidence and Launch Excellence, Novartis
Bio: https://www.linkedin.com/in/amy-rudolph-4a749639

20 min moderated discussion led by Gil Bashe, Global Chair, Health Practice, Finn Partners

See you on Tues, Oct 19th, 10am ET: "What's Next for Real World Evidence?". To access: https://bit.ly/3jDXzTS